{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:10:33Z","timestamp":1790539833390,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.encep.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T01:07:53Z","timestamp":1632704873000},"page":"351-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Les traitements de substitution aux opiaces\u00a0: un parcours de respect de la dignit\u00e9 de la personne humaine"],"prefix":"10.1016","volume":"48","author":[{"given":"S.","family":"Richa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Lucet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Laqueille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2021.03.006_bib0080","series-title":"Quels sont les freins \u00e0 la prise en charge des patients sous traitement de substitution aux opiaces par les m\u00e9decins g\u00e9n\u00e9ralistes\u00a0? Th\u00e8se d\u2019exercice en M\u00e9decine, Universit\u00e9 Claude Bernard Lyon 1","author":"Deville","year":"2020"},{"key":"10.1016\/j.encep.2021.03.006_bib0085","first-page":"1669","article-title":"Substitution aux opiac\u00e9s\u00a0: programme de la derni\u00e8re chance ou pari sur la qualit\u00e9 de vie\u00a0?","volume":"9","author":"Manghi","year":"2013","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.encep.2021.03.006_bib0090","series-title":"Drogues et substitution. Traitements et prise en charge du sujet","author":"Jacques","year":"2006"},{"issue":"2","key":"10.1016\/j.encep.2021.03.006_bib0095","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3917\/lae.092.0006","article-title":"Quelle \u00e9thique m\u00e9dicale face aux pathologies addictives\u00a0?","volume":"57","author":"Laqueille","year":"2009","journal-title":"Laennec"},{"key":"10.1016\/j.encep.2021.03.006_bib0100","series-title":"Manuel de \u00c9thique m\u00e9dicale. Sous la direction de Sami Richa","year":"2019"},{"key":"10.1016\/j.encep.2021.03.006_bib0105","unstructured":"Haute autorit\u00e9 de la sant\u00e9, Conf\u00e9rence de consensus. \u00ab\u00a0Strat\u00e9gies th\u00e9rapeutiques pour les personnes d\u00e9pendantes des opiac\u00e9s\u00a0: place des traitements de substitution\u00a0\u00bb. 23\u00a0et 24\u00a0juin 2004, France."},{"key":"10.1016\/j.encep.2021.03.006_bib0110","unstructured":"Louesse C. Les risques li\u00e9s au traitement de substitution aux opiac\u00e9s par l\u2019usage de m\u00e9thadone.Travail de fin d\u2019\u00e9tude r\u00e9alis\u00e9 en vue de l\u2019obtention du DES en m\u00e9decine g\u00e9n\u00e9rale, Universit\u00e9 Catholique de Louvain, 2009\u20132010. https:\/\/eurotox.org\/wp\/wp-content\/uploads\/BE_Les-risques-li\u00e9s-au-traitement-de-substitution-aux-opiac\u00e9s-par-l\u2019usage-de-m\u00e9thadone-2010.pdf."},{"key":"10.1016\/j.encep.2021.03.006_bib0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.encep.2021.03.006_bib0120","first-page":"173","article-title":"Aspects \u00e9thiques particuliers \u00e0 la substitution","author":"Jacques","year":"2006","journal-title":"Oxalis"},{"key":"10.1016\/j.encep.2021.03.006_bib0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3917\/ds.251.0099","article-title":"La marge en cause dans le discours de toxicomanes","volume":"25","author":"Houdayer","year":"2001","journal-title":"D\u00e9viance et Soci\u00e9t\u00e9"},{"key":"10.1016\/j.encep.2021.03.006_bib0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3917\/psyt.193.0149","article-title":"Les seuils de la substitution\u00a0: regard sociologique sur l\u2019acc\u00e8s aux traitements de substitution aux opiac\u00e9s","volume":"19","author":"Dassieu","year":"2013","journal-title":"Psychotropes"},{"key":"10.1016\/j.encep.2021.03.006_bib0135","series-title":"Cadre de r\u00e9f\u00e9rence et guide de bonnes pratiques pour orienter le traitement de la d\u00e9pendance aux opio\u00efdes avec une m\u00e9dication de substitution. Direction des communications du Minist\u00e8re de la sant\u00e9 et des services sociaux","year":"2006"},{"issue":"2","key":"10.1016\/j.encep.2021.03.006_bib0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000438988","article-title":"The impact of misuse and diversion of opioid substitution treatment medicines: evidence review and expert consensus","volume":"22","author":"Reimer","year":"2016","journal-title":"Eur Addict Res"},{"issue":"1","key":"10.1016\/j.encep.2021.03.006_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11606-016-3799-7","article-title":"Barriers to post-acute care for patients on opioid agonist therapy; an example of systematic stigmatization of addiction","volume":"32","author":"Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"20","key":"10.1016\/j.encep.2021.03.006_bib0075","first-page":"326","article-title":"Addiction ou la tentation du risque","volume":"14","author":"Burri","year":"2014","journal-title":"Primary Care"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621001263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700621001263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T17:40:46Z","timestamp":1757958046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700621001263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0013700621001263"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2021.03.006","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les traitements de substitution aux opiaces\u00a0: un parcours de respect de la dignit\u00e9 de la personne humaine","name":"articletitle","label":"Article Title"},{"value":"L'Enc\u00e9phale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.encep.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 L'Enc\u00e9phale, Paris.","name":"copyright","label":"Copyright"}]}}